By proceeding, you agree to our Terms of Use and Privacy Policy.
The European Society for Translational Medicine (EUSTM) cordially invites you to attend the 9th Annual Congress of the European Society for Translational Medicine on Immunotherapeutics – From Biology to Patient Care (EUSTM-2022) held in virtual format during 3-5 October, 2022.
Exchange, discuss and network with key stakeholders in academic research, clinical care, and public health.
The Congress will focus on recent advances in the field of immunotherapeutics for solid tumors, hematological malignancies, autoimmune disorders & more.
Professors from Harvard Medical School & more will discuss a practical approach to selection of first-line treatment for metastatic urothelial cancer.
The event provides a platform for scientific exchange and discussion about the recent progress in immunotherapies for cancer and infectious diseases.
The European Society for Translational Medicine (EUSTM) is a global non-profit neutral platform for the advancement and progress of Translational Medicine by offering high quality educational programs and events.
Incyte is a global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.